Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Other Operating Expenses: 2010-2023

Historic Other Operating Expenses for Altimmune (ALT) over the last 5 years, with Dec 2023 value amounting to $12.4 million.

  • Altimmune's Other Operating Expenses was N/A to $12.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $24.8 million, marking a year-over-year change of. This contributed to the annual value of $12.4 million for FY2023, which is N/A change from last year.
  • According to the latest figures from Q4 2023, Altimmune's Other Operating Expenses is $12.4 million, which was up 276.33% from $3.3 million recorded in Q4 2021.
  • Altimmune's 5-year Other Operating Expenses high stood at $12.4 million for Q4 2023, and its period low was $1.0 million during Q3 2019.
  • In the last 2 years, Altimmune's Other Operating Expenses had a median value of $8.1 million in 2021 and averaged $7.9 million.
  • Data for Altimmune's Other Operating Expenses shows a peak YoY spiked of 103.02% (in 2019) over the last 5 years.
  • Over the past 3 years, Altimmune's Other Operating Expenses (Quarterly) stood at $1.0 million in 2019, then followed by $3.3 million in 2021, then followed by $12.4 million in 2023.
  • Its last three reported values are $12.4 million in Q4 2023, $3.3 million for Q4 2021, and $8.1 million during Q2 2021.